WEIDINGER, S.; PINK, A.; FRANCISCO, J.; KURBASIC, A.; OLSEN, C.; VILSB?LL, A.; DE BRUIN WELLER, M. Tralokinumab Improves Clinically Relevant Outcome Measures: A Post Hoc Analysis of ECZTRA 3, A Randomized Clinical Trial in Patients with Moderate-To-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 6, p. s100, 2020. DOI: 10.25251/skin.4.supp.100. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/1077. Acesso em: 3 jul. 2024.